261 related articles for article (PubMed ID: 31349410)
21. Synthesis, characterization, and in vitro anti-tumor activity studies of the hyaluronic acid-mangiferin-methotrexate nanodrug targeted delivery system.
Wang H; Shao W; Lu X; Gao C; Fang L; Yang X; Zhu P
Int J Biol Macromol; 2023 Jun; 239():124208. PubMed ID: 36972827
[TBL] [Abstract][Full Text] [Related]
22. Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy.
Zhou M; Hou J; Zhong Z; Hao N; Lin Y; Li C
Drug Deliv; 2018 Nov; 25(1):716-722. PubMed ID: 29516758
[TBL] [Abstract][Full Text] [Related]
23. Combination of NF-kB targeted siRNA and methotrexate in a hybrid nanocarrier towards the effective treatment in rheumatoid arthritis.
Duan W; Li H
J Nanobiotechnology; 2018 Jul; 16(1):58. PubMed ID: 30060740
[TBL] [Abstract][Full Text] [Related]
24. Hybrid Nanoparticles Modified by Hyaluronic Acid Loading an HSP90 Inhibitor as a Novel Delivery System for Subcutaneous and Orthotopic Colon Cancer Therapy.
Pan C; Zhang T; Li S; Xu Z; Pan B; Xu S; Jin S; Lu G; Yang S; Xue Z; Chen P; Shen X; Wang F; Xu C
Int J Nanomedicine; 2021; 16():1743-1755. PubMed ID: 33688189
[TBL] [Abstract][Full Text] [Related]
25. Nanogold-core multifunctional dendrimer for pulsatile chemo-, photothermal- and photodynamic- therapy of rheumatoid arthritis.
Pandey PK; Maheshwari R; Raval N; Gondaliya P; Kalia K; Tekade RK
J Colloid Interface Sci; 2019 May; 544():61-77. PubMed ID: 30825801
[TBL] [Abstract][Full Text] [Related]
26. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
[TBL] [Abstract][Full Text] [Related]
27. Targeted chemo-photothermal treatments of rheumatoid arthritis using gold half-shell multifunctional nanoparticles.
Lee SM; Kim HJ; Ha YJ; Park YN; Lee SK; Park YB; Yoo KH
ACS Nano; 2013 Jan; 7(1):50-7. PubMed ID: 23194301
[TBL] [Abstract][Full Text] [Related]
28. Co-association of methotrexate and SPIONs into anti-CD64 antibody-conjugated PLGA nanoparticles for theranostic application.
Moura CC; Segundo MA; Neves Jd; Reis S; Sarmento B
Int J Nanomedicine; 2014; 9():4911-22. PubMed ID: 25364249
[TBL] [Abstract][Full Text] [Related]
29. Methotrexate-loaded multifunctional nanoparticles with near-infrared irradiation for the treatment of rheumatoid arthritis.
Ha YJ; Lee SM; Mun CH; Kim HJ; Bae Y; Lim JH; Park KH; Lee SK; Yoo KH; Park YB
Arthritis Res Ther; 2020 Jun; 22(1):146. PubMed ID: 32552859
[TBL] [Abstract][Full Text] [Related]
30. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F
J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948
[TBL] [Abstract][Full Text] [Related]
31. Preparation, evaluation, and first clinical use of 177Lu-labeled hydroxyapatite (HA) particles in the treatment of rheumatoid arthritis: utility of cold kits for convenient dose formulation at hospital radiopharmacy.
Chakraborty S; Vimalnath KV; Rajeswari A; Shinto A; Sarma HD; Kamaleshwaran K; Thirumalaisamy P; Dash A
J Labelled Comp Radiopharm; 2014 Jun; 57(7):453-62. PubMed ID: 24966157
[TBL] [Abstract][Full Text] [Related]
32. Formulation and
Mercanoglu G; Alcın G; Ozturkmen Y; Cermik T
Curr Radiopharm; 2024; 17(1):68-76. PubMed ID: 37937551
[TBL] [Abstract][Full Text] [Related]
33. Development of a hyperbranched polymer-based methotrexate nanomedicine for rheumatoid arthritis.
Marasini N; Er G; Fu C; Subasic CN; Ibrahim J; Skwarczynski M; Toth I; Whittaker AK; Kaminskas LM
Acta Biomater; 2022 Apr; 142():298-307. PubMed ID: 35114374
[TBL] [Abstract][Full Text] [Related]
34. A hyaluronic acid-methotrexate conjugate for targeted therapy of rheumatoid arthritis.
Shin JM; Kim SH; Thambi T; You DG; Jeon J; Lee JO; Chung BY; Jo DG; Park JH
Chem Commun (Camb); 2014 Jul; 50(57):7632-5. PubMed ID: 24893961
[TBL] [Abstract][Full Text] [Related]
35. Preparation and Evaluation of
Ghosh S; Das T; Sarma HD; Dash A
Cancer Biother Radiopharm; 2017 Sep; 32(7):239-246. PubMed ID: 28876087
[TBL] [Abstract][Full Text] [Related]
36. Colon-specific delivery of methotrexate using hyaluronic acid modified pH-responsive nanocarrier for the therapy of colitis in mice.
Lv Y; Ren M; Yao M; Zou J; Fang S; Wang Y; Lan M; Zhao Y; Gao F
Int J Pharm; 2023 Mar; 635():122741. PubMed ID: 36804523
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of intra-articular delivery of hyaluronic acid functionalized biopolymeric nanoparticles in healthy rat knees.
Zille H; Paquet J; Henrionnet C; Scala-Bertola J; Leonard M; Six JL; Deschamp F; Netter P; Vergès J; Gillet P; Grossin L
Biomed Mater Eng; 2010; 20(3):235-42. PubMed ID: 20930333
[TBL] [Abstract][Full Text] [Related]
38. Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancer.
Chakraborty S; Das T; Sarma HD; Venkatesh M; Banerjee S
Nucl Med Biol; 2008 Jul; 35(5):589-97. PubMed ID: 18589303
[TBL] [Abstract][Full Text] [Related]
39. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
Sargazi A; Shiri F; Keikha S; Majd MH
Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
[TBL] [Abstract][Full Text] [Related]
40. Targeting CD34
Colombo F; Durigutto P; De Maso L; Biffi S; Belmonte B; Tripodo C; Oliva R; Bardini P; Marini GM; Terreno E; Pozzato G; Rampazzo E; Bertrand J; Feuerstein B; Javurek J; Havrankova J; Pitzalis C; Nuñez L; Meroni P; Tedesco F; Sblattero D; Macor P
J Autoimmun; 2019 Sep; 103():102288. PubMed ID: 31213399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
